We are live on
!
Find out more
BCM
Bluefin Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
18.42%
This Fund
S&P 500
This Quarter
Est. Return
+4.49%
1 Year Est. Return
+18.42%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.01B
AUM Growth
+$11.5M
(+1.2%)
Cap. Flow
+$1.03B
Cap. Flow
% of AUM
102.56%
Top 10 Holdings %
Top 10 Hldgs %
47.49%
Holding
702
New
252
Increased
126
Reduced
88
Closed
204
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$102M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$35.6M |
| 3 |
Invesco CurrencyShares British Pound Sterling Trust
FXB
|
+$32.3M |
| 4 |
WY.PRA
WEYERHAEUSER COMP PREF CONV SER A (WA)
WY.PRA
|
+$29.7M |
| 5 |
PNK
Pinnacle Entertainment Inc.
PNK
|
+$27.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$71.9M |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$38M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$24M |
| 4 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$18.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$13.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.06% |
| 2 | Energy | 7.43% |
| 3 | Materials | 7.26% |
| 4 | Technology | 6.51% |
| 5 | Financials | 3.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CALL
Petrobras
PBR
$119B
| $832K | 0.08% |
746,200
+292,600
| +65% | +$1.94M |
|
152
Qualcomm
QCOM
$168B
| $830K | 0.08% |
+15,494
| New | +$816K |
|
|
LNW
153
DELISTED
Light & Wonder
LNW
| $828K | 0.08% |
90,084
+59,594
| +195% | +$563K |
|
154
CALL
Tesla
TSLA
$1.26T
| $827K | 0.08% |
262,500
-637,500
| -71% | -$9.66M |
|
155
VanEck Emerging Markets High Yield Bond ETF
HYEM
$522M
| $825K | 0.08% |
+34,710
| New | +$808K |
|
156
iShares MSCI Europe Financials ETF
EUFN
$4.26B
| $824K | 0.08% |
+52,580
| New | +$943K |
|
157
PUT
Vale
VALE
$62.6B
| $813K | 0.08% |
1,254,400
+239,000
| +24% | +$1.12M |
|
158
Sprott Physical Gold
PHYS
$15.3B
| $799K | 0.08% |
72,747
-221,553
| -75% | -$2.32M |
|
|
EMAG
159
DELISTED
VanEck Vectors Emerging Markets Aggregate Bond ETF
EMAG
| $796K | 0.08% |
+37,448
| New | +$788K |
|
160
State Street Health Care Select Sector SPDR ETF
XLV
$42.4B
| $766K | 0.08% |
10,675
-325
| -3% | -$22.9K |
|
161
MetLife
MET
$64.3B
| $756K | 0.08% |
21,309
+13,476
| +172% | +$526K |
|
162
AbbVie
ABBV
$431B
| $739K | 0.07% |
11,937
-698
| -6% | -$42.5K |
|
163
iShares Intermediate Government/Credit Bond ETF
GVI
$3.77B
| $734K | 0.07% |
+6,476
| New | +$726K |
|
164
Merck
MRK
$317B
| $734K | 0.07% |
13,355
+9,328
| +232% | +$496K |
|
165
Procter & Gamble
PG
$342B
| $729K | 0.07% |
8,607
+3,502
| +69% | +$287K |
|
166
Stanley Black & Decker
SWK
$15.3B
| $726K | 0.07% |
+6,528
| New | +$726K |
|
167
NXP Semiconductors
NXPI
$58.4B
| $722K | 0.07% |
+9,222
| New | +$791K |
|
168
Diageo
DEO
$51.6B
| $716K | 0.07% |
+6,347
| New | +$686K |
|
169
CALL
Genesis Energy
GEL
$1.86B
| $710K | 0.07% |
626,000
+228,500
| +57% | +$8M |
|
170
Philip Morris
PM
$293B
| $710K | 0.07% |
6,981
-4,019
| -37% | -$401K |
|
171
CALL
ProShares Short VIX Short-Term Futures ETF
SVXY
$206M
| $708K | 0.07% |
200,500
+190,500
| +1,905% | +$10.3M |
|
|
LNKD
172
CALL
DELISTED
LinkedIn Corporation
LNKD
| $698K | 0.07% |
+30,000
| New | +$4.16M |
|
173
Unilever
UL
$137B
| $696K | 0.07% |
+12,917
| New | +$663K |
|
|
174
PUT
Petrobras
PBR
$119B
| $694K | 0.07% |
1,290,800
+729,700
| +130% | +$4.83M |
|
175
Cal-Maine
CALM
$3.98B
| $681K | 0.07% |
+15,376
| New | +$725K |
|
Similar funds
PMSA
CFG
BCM
BWM
MCA
HAM
SPM
DWM
Bluefin Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Bluefin Capital Management held 702 positions worth $1.01B, up 1.2% from $995M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Bluefin Capital Management deployed $1.03B of net new capital in Q2 2016, opening 252 new positions and adding to 126 existing holdings. Its largest new stake was Allergan plc: 443,994 shares worth $103M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.9% a quarter earlier, followed by Energy and Materials.
On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $38M trimmed.
- Bluefin Capital Management's largest Q2 2016 buy was Allergan plc: 443,994 shares worth $103M.
- Bluefin Capital Management added most to EMC CORPORATION in Q2 2016, an estimated $17.8M increase.
- Bluefin Capital Management's biggest Q2 2016 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $38M.
- Bluefin Capital Management fully exited Baxter International in Q2 2016, selling an estimated $71.9M.
- Bluefin Capital Management's ten largest holdings make up 47% of its $1.01B portfolio in Q2 2016.
- Bluefin Capital Management opened 252 new positions and closed 204 in Q2 2016.
- Bluefin Capital Management's portfolio value rose 1.2% quarter-over-quarter to $1.01B.
Based on Bluefin Capital Management's 13F filing for Q2 2016, filed 16 Aug 2016.